• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Health & Medicine

Immunotherapy treatment recommended for advanced small cell lung cancer 

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer. A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

5 June 2020

• Health & Medicine

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer. Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

26 May 2020

• Science & Technology
• Health & Medicine

News digest – ‘stealth’ nanoparticles, children’s brain tumours, lung cancer immunotherapy and aspirin

Scientists have developed nanoparticles that can slip through the blood-brain barrier in mice. Scientists have developed nanoparticles that can slip through the blood-brain barrier in mice.

18 April 2020

• Health & Medicine

Lung cancer immunotherapy gets initial ‘no’ for NHS in England

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England. An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

8 January 2020

• Science & Technology

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer

17 December 2019

• Science & Technology
• Health & Medicine

News digest – heart health risks, immunotherapy trials, prostate cancer urine test and living with cancer

In the news this week: new estimates suggest there are now nearly 3 million people in the UK living with cancer and some promising immunotherapy trial results. In the news this week: new estimates suggest there are now nearly 3 million people in the UK living with cancer and some promising immunotherapy trial results.

30 November 2019

• For Researchers

Walking the path to leadership in cancer immunotherapy: Dr Sean Lim, Advanced Clinician Scientist Fellow

Dr Sean Lim tells us about her successful progression from Clinician Scientist Fellow to Advanced Clinician Scientist Fellow. Dr Sean Lim tells us about her successful progression from Clinician Scientist Fellow to Advanced Clinician Scientist Fellow.

7 October 2019

• Science & Technology
• Health & Medicine

News digest – breast cancer survival, melanoma immunotherapy, red meat and cigarette warnings 

In the news this week: record numbers of people beating breast cancer and long-term benefits of melanoma immunotherapy revealed. In the news this week: record numbers of people beating breast cancer and long-term benefits of melanoma immunotherapy revealed.

5 October 2019

• Health & Medicine

Immunotherapy for triple negative breast cancer gets initial ‘no’ for NHS in England

An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England. An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.

3 October 2019

• Science & Technology

Tasmanian devil research could help tackle immunotherapy resistance

A cluster of interacting proteins active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system A cluster of interacting proteins active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system

27 September 2019

• Science & Technology
• Health & Medicine

What can tumours in Tasmanian devils teach us about immunotherapy resistance?

A peculiar type of tumour, in an even more peculiar type of animal, could hold some clues to help scientists overcome immunotherapy resistance in humans. A peculiar type of tumour, in an even more peculiar type of animal, could hold some clues to help scientists overcome immunotherapy resistance in humans.

26 September 2019